Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapy.
Stockholm University, Faculty of Science, Department of Genetics, Microbiology and Toxicology.
2008 (English)In: Eur J Cancer, ISSN 0959-8049, Vol. 44, no 7, 921-7 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2008. Vol. 44, no 7, 921-7 p.
Keyword [en]
Antineoplastic Agents/*therapeutic use, Cell Hypoxia/drug effects, DNA Damage, DNA Repair, DNA Replication/drug effects, Humans, Mutation/genetics, Neoplasms/*drug therapy/genetics, Oncogenes/*drug effects, Targeted Gene Repair
Identifiers
URN: urn:nbn:se:su:diva-16644ISI: 000256673900012PubMedID: 18374562OAI: oai:DiVA.org:su-16644DiVA: diva2:183164
Available from: 2008-12-19 Created: 2008-12-19 Last updated: 2011-01-10Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=18374562&dopt=Citation

Search in DiVA

By author/editor
Helleday, Thomas
By organisation
Department of Genetics, Microbiology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 102 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf